Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Dialysis Clinical Outcomes Revisited (DCOR) Trial

ClinicalTrials.gov ID: NCT00324571

Public ClinicalTrials.gov record NCT00324571. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 11:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open Label, Parallel Design Study of Renagel® Phosphate Binder Versus Calcium-Based Phosphate Binders in Hemodialysis Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, open-label, parallel-design study to be conducted at 75 centers within the United States. The study will be described to hemodialysis patients. Informed consent will be obtained and the inclusion/exclusion criteria reviewed. Eligible patients will be randomized to receive either Renagel or a calcium-based binder. Starting from the randomization date, mortality data including survival, death date and cause of death (vital status information) and morbidity data including hospitalization date will be recorded for all patients. These data will be collected until the end of the study (December 31, 2004, ± 2 weeks). Patients completing or terminating from the study will return to the phosphate binder prescribed by their usual healthcare provider.

Study identification

NCT ID
NCT00324571
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Genzyme, a Sanofi Company
Industry
Enrollment
2,000 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2001 (Type not available)
Primary completion
Not listed
Completion
Feb 2006 (Type not available)
Last update posted
Mar 18, 2015

2001 – 2006

United States locations

U.S. sites
72
U.S. states
26
U.S. cities
66
Facility City State ZIP Site status
Gambro Healthcare-Gadsden Gadsden Alabama — —
nTouch Research Huntsville Alabama — —
Kidney Health Institute, LLC Tucson Arizona — —
Gambro Healthcare El Cerrito California — —
Palomar Medical Group Escondido California — —
Gambro Healthcare-Los Angeles Los Angeles California — —
Balboa Nephrology Medical Group San Diego California — —
Nephrology Educational Services and Research Tarzana California — —
Lowry Dialysis Center Denver Colorado — —
Nephrology Associates, P.C. Bridgeport Connecticut — —
Gambro Healthcare-Hartford Hartford Connecticut — —
Nephrology Associates New Britain Connecticut — —
InterAmerican Dialysis Coral Gables Florida — —
DaVita Crystal River Dialysis Crystal River Florida — —
Gambro Healthcare-Miami Miami Florida — —
Miami Kidney Group Miami Florida — —
Pensacola Nephrology, P.A. Pensacola Florida — —
Gambro Healthcare-Plantation Plantation Florida — —
America Dialysis St. Petersburg Florida — —
Genesis Clinical Research Corp Tampa Florida — —
Gambro Healthcare-Americus Americus Georgia — —
nTouch Research Atlanta Georgia — —
Gambro Healthcare-Douglas Douglas Georgia — —
Gambro Healthcare-Douglasville Douglasville Georgia — —
Dublin Nephrology Dublin Georgia — —
Georgia Kidney Associates, Inc. Marietta Georgia — —
Gambro Healthcare-Rome Rome Georgia — —
Gambro Healthcare-Savannah Savannah Georgia — —
MacNeal Renal Lifeline Services Berwyn Illinois — —
Southwest Nephrology Evergreen Park Illinois — —
Horizon Healthcare Associates Olympia Fields Illinois — —
Renal Care Associates, S.C. Peoria Illinois — —
Gambro Healthcare-Springfield Central Springfield Illinois — —
Lincolnland Dialysis Springfield Illinois — —
Nephrology Specialists, PC. Valparaiso Indiana — —
Wichita Dialysis Center East Wichita Kansas — —
Wichita Nephrology Wichita Kansas — —
Northwest Louisiana Nephrology, LLC. Shreveport Louisiana — —
BMA of Washington Bethesda Maryland — —
Gambro Healthcare-Frederick Frederick Maryland — —
Associates in Nephrology, P.C. Brockton Massachusetts — —
Western New England Renal and Transplant Associates, Inc. Springfield Massachusetts — —
DaVita Clinical Research Minneapolis Minnesota — —
Nephrology Associates, P.C. Columbus Mississippi 39705 —
University of Missouri-Kansas City Kansas City Missouri — —
DaVita Crystal City Dialysis St Louis Missouri — —
Nephrology and Endocrine Associates Las Vegas Nevada — —
Bronx Westchester Medical Group The Bronx New York — —
Mountain Kidney Associates, P.A. Asheville North Carolina — —
nTouch Research Raleigh North Carolina — —
Wake Nephrology/Wake Dialysis Clinic Raleigh North Carolina — —
Gambro Healthcare-Wilson Wilson North Carolina — —
Kidney and Hypertension Center Cincinnati Ohio 45220 —
Ohio State University College of Pharmacy Columbus Ohio — —
FMC of Bethlehem Allentown Pennsylvania — —
Fresenius Medical Care Greensburg Pennsylvania — —
Hypertension and Kidney Specialists Lancaster Pennsylvania — —
DaVita Lewistown Dialysis Center Lewistown Pennsylvania — —
Albert Einstein Medical Center Philadelphia Pennsylvania 19141 —
P.C. & Associates Philadelphia Pennsylvania — —
Nesbitt College of Pharmacy and Nursing Department of Pharmacy Practice Wilkes-Barre Pennsylvania — —
Gambro Healthcare-Aiken Aiken South Carolina — —
Midsouth Nephrology Consultants Memphis Tennessee — —
Dallas Nephrology Associates Dallas Texas — —
Nephrology, Dialysis and Transplant Association Houston Texas — —
West Houston Dialysis Houston Texas — —
San Antonio Kidney Disease Center San Antonio Texas — —
Gambro Healthcare - Charlottesville Charlottesville Virginia 22902 —
Clinical Research and Consulting Center, LLC Fairfax Virginia — —
Clinical Research of Tidewater Norfolk Virginia 23507 —
Virginia Commonwealth University, Division of Nephrology Richmond Virginia 23298 —
Vancouver Clinic Inc., P.S. Vancouver Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00324571, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 18, 2015 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00324571 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →